Recent Lessons

Show all results for ""

Feature Overview

Ace your exams with our all-in-one platform for creating and sharing quizzes and tests.

Free Tools

Explore our collection of AI-powered tools designed to boost your productivity.

Flashcards

Automatically turn your notes into digital flashcards.

Share, Export & Embed

Share with classmates or export to Excel and your learning management system.

Stats & Reporting

Auto-grading quizzes and tests with detailed stats and reports.

Mobile Apps

The smarter way to study – wherever you are.

Pricing Schools Business

Features Free Tools Pricing Schools Business

Haemophilia Bleeding Events and Classification

10 Questions

0 Views

Haemophilia Bleeding Events and Classification

Choose a study mode

Play Quiz

Study Flashcards

Spaced Repetition

Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the recurrence rate of VTE in the first year for patients without identifiable transient risk factors?

15%
20%
10% (correct)
5%

What is the recommended approach for anticoagulation in patients with a second unprovoked VTE?

Low-dose anticoagulation for 3-6 months
Indefinite anticoagulation (correct)
No anticoagulation required
Full-dose anticoagulation for 1 year

What is the benefit of using low-dose apixaban or rivaroxaban in patients with unprovoked VTE?

Reduced bleeding risk with increased efficacy
Increased efficacy with increased bleeding risk
Reduced efficacy with no significant increase in bleeding risk
Same efficacy with no significant increase in bleeding risk (correct)

What is the anticoagulant of choice for cancer patients with VTE?

LMWH (e.g. enoxaparin) (D) Signup and view all the answers

Why are cancer patients more likely to die from VTEs?

Due to complications and increased risk of VTEs (B) Signup and view all the answers

What is the recommended anticoagulation approach for patients with cancer-associated thrombosis?

Indefinite anticoagulation unless cure is achieved (C) Signup and view all the answers

Why are pregnant women at increased risk of VTEs?

Due to venous stasis, endothelial injury, and hypercoagulability (A) Signup and view all the answers

What is the anticoagulant of choice during pregnancy and breastfeeding?

LMWH (e.g. enoxaparin) (A) Signup and view all the answers

What is the benefit of using apixaban or rivaroxaban in cancer patients with VTEs?

Possible higher bleeding risk in GI cancer (B) Signup and view all the answers

What is the goal of extended anticoagulation beyond 3-6 months in patients with unprovoked VTE?

To reduce the risk of recurrence (D) Signup and view all the answers